Melissa Haussman. 2013. Reproductive Rights and the State: Getting the Birth Control, RU‐486, and Morning‐After Pills and the Gardasil Vaccine to the U.S. Market. (Reproductive Rights and Policy Series; Series Editor, Judith A. Baer). Santa Barbara, CA: Praeger. $37.00. Hardcover. pp. 184. ISBN 978‐0‐313‐39822‐3.

AuthorKaren Baird
DOIhttp://doi.org/10.1002/wmh3.128
Published date01 March 2015
Date01 March 2015
Book Review
Melissa Haussman. 2013. Reproductive Rights and the State: Getting the Birth Control,
RU-486, and Morning-After Pills and the Gardasil Vaccine to the U.S. Market.
(Reproductive Rights and Policy Series; Series Editor, Judith A. Baer). Santa Barbara,
CA: Praeger. $37.00. Hardcover. pp. 184. ISBN 978-0-313-39822-3.
In Reproductive Rights and the State, Melissa Haussman, Professor of Political
Science at Carleton University, brings together reproductive rights, drugs,
abortion, birth control, and the HPV vaccine to compare their intertwined politics.
Why did the Gardasil vaccine f‌ly through the FDA approval process, but RU-486
(i.e., medical abortion) and the morning-after pill take years to receive FDA
approval? No pressing need had been demonstrated for the vaccine against HPV,
a sexually transmitted disease that can lead to cervical cancer, but doctors,
scientists, and women’s health advocates lobbied for decades for approval of the
birth control and RU-486.
Feminists often criticize social conservatives for attempting to control
women’s bodies and sexuality through punitive public policies. As all of the
drugs examined in Reproductive Rights and the State revolve around women’s, and
girls’, sexual conduct, how is it that the vaccine bypassed the usual moral
controversies? This quagmire is what Melissa Haussman explains by document-
ing how for-prof‌it pharmaceutical companies’ interests can sometimes triumph
over anti-reproductive rights interests. She writes, “This drug [Gardasil vaccine]
and Viagra for men, which was approved by the FDA in fewer than 6 months,
are the two outliers in the typical history of state and market neglect to develop
reproductive-related drugs” (p. 139). The many different groups involved in
reproductive rights policies and the different governmental levels and agencies
that regulate reproductive rights are also vividly documented.
Reproductive Rights and the State covers the pre- and post-Roe periods: pro-
reproductive rights arguments dominated the former and anti-reproductive rights
groups dominated the latter. The book details the f‌ight for FDA approval of
RU-486 and the morning-after pill and then, after its approval, the struggle to
make Plan B (a patented version of the morning-after pill) available over the
counter. Supporters in and out of government fought tirelessly by lobbying, f‌iling
World Medical & Health Policy, Vol. 7, No. 1, 2015
90
1948-4682 #2015 Policy Studies Organization
Published by Wiley Periodicals, Inc., 350 Main Street, Malden, MA 02148, USA, and 9600 Garsington Road, Oxford, OX42 DQ.

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT